Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH

Yatharth Hospital And Trauma Care Services — Q3 FY2024 Earnings Presentation

43 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Feb 10, 2024

  1. Slide 1: Cover letter to stock exchanges

    February 10, 2024 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 5

  2. Slide 2: Q3 & 9M FY24 Earnings Presentation

    www.yatharthhospitals.com Q3 & 9M FY24 Earnings Presentation February 10, 2024 1

  3. Slide 3: Disclaimer

    Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t

  4. Slide 4: Q3 & 9M FY24 Performance Highlights

    Q3 & 9M FY24 Performance Highlights 3

  5. Slide 5: Q3 & 9M FY24 Financial Highlights

    Q3 & 9M FY24 Financial Highlights Q3 9M Rs. 1,668 mn Rs. 4,926 mn +21% YoY +31% YoY Revenue Margin Margin Rs. 464 mn Rs. 1,334 mn 27.8% +29% YoY +40% YoY 27.1% +160bps YoY EBITDA +177bps YoY Margin Margin Rs. 295 mn Rs. 761 mn 15.5% 17.7% +39% YoY +57% YoY +223bps YoY PAT +259bps YoY ➢ Revenue up by

  6. Slide 6: Financial Highlights

    Financial Highlights Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% +21% +31% -3% 27.8% 27.1% 1600 1595 28% 1590 26.6% 1585 1580 1000 28% 1575 1570 26.2% 99 5 1565 99 0 1560 1555 98 5 1550 98 0 1545 1540 27% 25.3% 975 1535 1530 970 1525 96 5 27% 1520 1515 96 0 1510 95 5 1505 1500 95 0 1495 94 5 1490 1485

  7. Slide 7: Strengthened Balance Sheet

    Strengthened Balance Sheet Equity Base Expansion (Rs mn) 40% Debt Repayment – 2,450 mn 8,109 Organic Capex – 1,326 mn 22% Rs 6,100 mn IPO Proceeds 11% 1,830 Inorganic Expansion – 650 mn 27% General Corporate & Issue Mar-23 Dec-23 Exps. – 1,674 mn Debt Repayment (Rs mn) 2,674 Ongoing Capex (Rs mn) Am

  8. Slide 8: Profit & Loss Summary

    Profit & Loss Summary Change Change Change Particulars (Rs Mn) Q3FY24 Q3FY23 Q2FY24 9MFY24 9MFY23 YoY QoQ YoY Revenue from Operations 1,668 1,375 21% 1,713 (3%) 4,926 3,765 31% Medical Consumables & 315 228 38% 360 (13%) 956 672 42% Pharmacy items Employee Expenses 299 236 27% 284 5% 852 669 27% Oth

  9. Slide 9: Operational Highlights

    Operational Highlights ❑ Occupancy increased to 52% in Q3FY24 vs 49% in Q3FY23; Noida hospital reported highest occupancy levels of 83% during the quarter ❑ Inpatient revenue up by 22% YoY for the quarter, and 33% YoY for the nine-month period ❑ ALOS stood at 4.66 days in Q3FY24 compared to 4.95 day

  10. Slide 10: Operational KPIs

    Operational KPIs IPD & OPD Revenue (Rs mn) IPD & OPD Volumes (in ‘000s) IPD Revenue OPD Revenue IPD Volume OPD Volume 4,926 283 271 1,713 1,668 95 97 3,765 601 85 1,376 224 191 513 161 249 234 4,324 83 84 73 1,489 1,477 3,252 1,215 12 13 12 34 37 Q3FY23 Q2FY24 Q3FY24 9MFY23 9MFY24 Q3FY23 Q2FY24 Q3FY

  11. Slide 11: Operational KPIs: ARPOB and Occupancy

    Operational KPIs 4,926 Revenue (Rs mn) 3,765 1,713 1,668 1,754 1,376 1,4661,280 1,3861,530 952 517 455 367 613 488 529 582 433 559 37 83 94 67 256 Q3FY23 Q2FY24 Q3FY24 9MFY23 9MFY24 ARPOB (Rs) 34,287 33,577 32,581 29,806 29,309 28,914 28,316 27,561 26,380 26,117 25,902 25,804 25,589 25,363 24,869 19

  12. Slide 12: Our Specialties

    Our Specialties Diversified specialty services Noida extension hospital registered 9M FY24 31% 10% 9% 9% 7% 6% 5% 5% 5% 4% 4% 5% highest share of super specialties Nephrology & urology 2023 Oncology, 13% 31% 10% 10% 9% 9% 13% Cardiology Internal 12% 2022 50% Medicine 14% 9M Pulmonology FY24 8% 2021

  13. Slide 13: Business Highlights

    Business Highlights ❑On Feb 9, 2024, Yatharth Hospitals signed a definitive agreement for the acquisition of Asian Fidelis Hospital in Faridabad, Haryana for a consideration of INR 1,160 mn ❑During Q3 FY2024, Company started its Robotic Surgeries with installation of a Surgical and an Orthopedic Rob

  14. Slide 14: Acquisition of 200-bedded Asian Fidelis Hospital in Faridabad

    Acquisition of 200-bedded super specialty Asian Fidelis Hospital in Faridabad, Delhi NCR ✓ On Feb 9, 2024, Company signed a definitive agreement with Pristine Infracon Pvt Ltd and its shareholders for 100% acquisition of Asian Fidelis Hospital in Faridabad, Haryana for a purchase consideration of IN

  15. Slide 15: Yatharth Hospitals starts Robotic Surgeries

    Yatharth Hospitals starts Robotic Surgeries ✓ Company has installed Da Vinci X Surgical Robot and Stryker’s Orthopedic Robot at its Noida extension hospital during the quarter ✓ Yatharth Hospitals has taken a lead in conducting region’s first robotic surgery 14

  16. Slide 16: Yatharth Hospitals expands its transplant operations

    Yatharth Hospitals expands its transplant operations ✓ Noida Extension hospital performed its first living donor liver transplant during the quarter ✓ Till date, Yatharth Hospitals completes 100 successful kidney transplants 15

  17. Slide 17: Yatharth Hospitals secures ET Now Best Brands 2023 award

    Yatharth Hospitals secures ET Now Best Brands 2023 award ✓ Yatharth Hospitals has been awarded Best Brand for Excellence in Healthcare at the prestigious Economic Times (ET) Edge Best Brands Conclave 2023. This coveted recognition celebrates brands that consistently innovate and set the bar for cust

  18. Slide 18: About The Company

    About The Company 17

  19. Slide 19: At a Glance

    At a Glance Leading super specialty hospital in Delhi-NCR Among top 10 largest private hospitals One-stop destination for patient needs providing all of Delhi NCR region in terms of number levels of healthcare services from primary to tertiary of beds 2019 Noida Extension 4 10 1,405 Hospitals Center

  20. Slide 20: Our Journey

    Our Journey Growing presence across regions and services 2008 2013 2019 2023 Incorporation of Established our Commencement of Listing on NSE & BSE company and second 250 bedded our third hospital, commencement of hospital, in Noida Noida Extension operations hospital, in May 2019, pursuant to the ac

  21. Slide 21: Greater Noida Hospital Overview

    Greater Noida Hospital Overview Revenue from Operations (Rs mn) Provides a wide spectrum of super specialty services in the field of 1,994 cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, 1,702 1,754 1,466 urology, nephrology, oncology, gastroenterology etc. 811 Strategy to

  22. Slide 22: Noida Hospital Overview

    Noida Hospital Overview Revenue from Operations (Rs mn) Provides services across 30 specialties, including cardiac sciences, 1,721 orthopedics, nephrology, urology, neurosciences, gastroenterology, etc. 1,283 1,280 1,386 681 Strategy to improve ALOS and improve the combination of super specialties,

  23. Slide 23: Noida Extension Hospital Overview

    Noida Extension Hospital Overview Super specialties contribute 70% of the overall business at this hospital; Revenue from Operations (Rs mn) continued efforts to develop this hospital as a Centre of Excellence for 1,530 oncology and robotic surgeries 1,357 1,023 Liver transplant and robotic surgerie

  24. Slide 24: Jhansi – Orchha Hospital Overview

    Jhansi – Orchha Hospital Overview Revenue from Operations (Rs mn) One of the largest hospital in Jhansi-Orchha-Gwalior region, has 256 infrastructure to operate all the major super specialties 131 Acquired in FY22, aimed at further expanding into new geographies and 67 growing presence in the region

  25. Slide 25: Our Specialties

    Our Specialties Expanding share of high value specialties Revenue change - FY23 vs FY21 30 Specialties and FY21-23 CAGR 13% 66% 77% 72% 82% 65% 79% 108% 131% 209% 53% Super specialties including 10 Centers of FY2021 FY2023 Excellence (COE) Revenue (Rs. mn) Our COEs ➢ Centre of Internal Medicine 1,63

  26. Slide 26: Payer mix

    Payer mix Balanced revenue split between payer categories Self-payers FY2023 1,888 1,605 885 FY21 FY22 FY23 Self-payers Central, state and others and local Insurers through TPA 36% government 1,227 1,381 bodies 669 under government scheme FY21 FY22 FY23 37% Insurers acting through third party Govern

  27. Slide 27: Our Strengths

    \¢ 26 OUR STRENGTHS

  28. Slide 28: Strengths

    Strengths Among the leading super-specialty hospital Regional advantage in Delhi NCR Advanced and high-end medical Experienced and professional equipment and technology management team Track record of stable Team of highly qualified operating & financial medical professionals performance 27

  29. Slide 29: Leading hospital in Delhi NCR, attracts patients from adjoining states

    Leading hospital in Delhi NCR, attracts patients from adjoining states with inadequate healthcare facilities 2 of Yatharth’s hospitals are amongst top 10 largest private Delhi NCR region hospitals in Delhi NCR* Jhansi-Orchha- ➢ Noida, Greater Noida and Noida extension attract patients from the Gwali

  30. Slide 30: Regional Advantage

    Regional Advantage Integrating talent from First mover advantage in well-established allied building out network workforce across Tier II/III cities Promoters being Stronger local connect doctors, have better with people 29 connect with doctors

  31. Slide 31: Advanced and high-end medical equipment and technology

    Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce cutting-edge medical technology and state-of-the-art equipment • Catheterization Laboratory Diagnostic Certifications • Computerized Tomograph

  32. Slide 32: Team of highly qualified medical professionals

    Team of highly qualified medical professionals Number of Doctors (Sep’23) Full Time Employees (Sep’23) Paramedical, Nursing, 877 398 Visiting Specialist Resident Doctors, 164 Doctors, 253 Medical Resident Doctors, 224 Corporate and Medical Support Staff, Specialist Doctors, 224 1,823 Doctors, 253 At

  33. Slide 33: Experienced and professional management team

    Experienced and professional management team Leadership Promoted by experienced medical professionals, Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar Dr. Ajay Kumar Tyagi Dr. Kapil Kumar Chairman & Whole-time Director Managing Director Management Led by experienced and qualified professional management te

  34. Slide 34: Track record of stable operating and financial performance

    Track record of stable operating and financial performance Growth led by strong operational Optimizing Capex Allocation 1. Stable operating & efficiency: 1. Reinvesting in increasing bed financial performance 1. Streamlining clinical and capacity and opening new hospitals 2. Continued growth over th

  35. Slide 35: Growth Strategy

    Growth Strategy Continue to Introduce new Grow medical Augment scale Further leverage improve our specialties at tourism segment through organic technology to quality of care existing hospitals to attract and inorganic grow operations and operational international manner in current efficiencies pati

  36. Slide 36: Key Growth Drivers (1/2)

    Key Growth Drivers (1/2) Improving specialty mix Introduce new specialties at Grow medical tourism segment towards high value specialties existing hospitals to attract international patients ➢ Increase in share of higher value ➢ Noida Extension taking the lead by ➢ Close proximity to the upcoming sp

  37. Slide 37: Key Growth Drivers (2/2)

    Key Growth Drivers (2/2) Leverage technology to grow Improving utilization & Jhansi Targeting Balanced Growth operations hospital stabilization ➢ Augment scale through organic ➢ Adopt the latest medical ➢ Focus towards increasing ARPOB and inorganic manner in current technologies and equipment to an

  38. Slide 38: Appendix

    Appendix 37

  39. Slide 39: Board of Directors (1/2)

    Board of Directors (1/2) Dr. Ajay Kumar Tyagi Dr. Kapil Kumar Yatharth Tyagi Chairman & Whole-time Director Managing Director Whole-time Director ➢ Over 17 years of experience in medical ➢ Over 17 years of experience in medicine ➢ Associated with the company since 2019 care and hospital management a

  40. Slide 40: Board of Directors (2/2)

    Board of Directors (2/2) Promila Bhardwaj Mukesh Sharma Sanjeev Upadhyaya Independent Director Independent Director Independent Director ➢ Over 35 years of experience in public ➢ Over 35 years of experience in banking ➢ Over 20 years of experience in administration ➢ Previously associated with Bank

  41. Slide 41: Management Team

    Management Team Amit Kumar Singh Pankaj Prabhakar Deepak Kumar Tyagi Chief Executive Officer Chief Financial Officer President, Strategy and Finance ➢ Over 17 years of experience in hospital ➢ Over 16 years of experience incorporate ➢ Approximately 14 years of experience management finance of severa

  42. Slide 42: Shareholding Pattern

    Shareholding Pattern Shareholding Pattern* BSE Ticker 543950 22.15% NSE Ticker YATHARTH 2.59% 8.81% Market Capitalization* 66.44% Rs. 32,357 mn No. of shares outstanding 8,58,50,233 Promoter Group DIIs FIIs Others 41 * As on December 31, 2023

  43. Slide 43: Thank You

    Thank You www.yatharthhospitals.com Yatharth Hospital & Trauma Care Services Ltd CIN: L85110DL2008PLC174706 www.yatharthhospitals.com Investor Relations investor.relations@yatharthhospitals.com 42

Yatharth Hospital & Trauma Care Services — Q3 FY2024 Earnings Presentation on 6ix